サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571814

医療グレード超高分子量ポリエチレンモノマーの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2024年～2030年

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Size, Share & Trends Analysis Report By Application (Knee Replacement, Hip Replacement), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.63円
医療グレード超高分子量ポリエチレンモノマーの市場規模、シェア、動向分析レポート：用途別、地域別、セグメント予測、2024年～2030年
出版日: 2024年09月23日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

医療グレード超高分子量ポリエチレンモノマー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の医療グレード超高分子量ポリエチレンモノマーの市場規模は、2024年から2030年にかけて9.5%のCAGRを記録し、2030年までに41億6,000万米ドルに達する見込みです。

高い衝撃強度、低い反応性、良好な柔軟性などの優れた特性により、医療用インプラントにおけるこの材料の有効性が、予測期間中の需要を促進すると予想されています。

UHMWPEは長い鎖を持つ材料であり、これにより荷重を効率的に伝達できるため、インプラント用途に適しています。この材料は非常に柔軟で、衝撃強度が高いです。また、金属に比べて軽量です。これらすべての特性により、医療用途におけるUHMWPEの需要は近年高まっており、この動向は予測期間中も続くと予想されます。

関節置換術では、その有効性と汎用性のオプションから超高分子量ポリエチレンが使用されています。世界中で関節置換術の需要が急増しています。高齢者人口の増加、ライフスタイルの変化、体力不足がこの動向の要因です。この動向は、今後8年間の全体的な需要にプラスに働くと予想されます。

主要な業界参加者は、より長寿命で、より快適で、強力な機械的性能を持つ革新的な移植可能製品を開発しようとしています。市場の特徴は、少数の企業が圧倒的な収益シェアを占めていることです。各社は需要の高まりに対応するため、製品ポートフォリオと生産能力の増強に取り組んでいます。

医療グレード超高分子量ポリエチレンモノマー市場のレポートハイライト

  • 人工膝関節置換術は、変形性関節症やその他の関節関連疾患の有病率の増加により、2023年には40.9%と圧倒的なシェアを占めています。
  • 股関節全置換術は、変形性関節症や関節リウマチの有病率の上昇により、予測期間中にCAGRが最も急成長すると予想されます。
  • アジア太平洋の医療グレード超高分子量ポリエチレンモノマー市場は、2023年に40.5%の市場シェアを記録しました。
  • 北米の医療グレード超高分子量ポリエチレンモノマー市場は、2023年に26.0%の市場シェアを確保しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 医療グレード超高分子量ポリエチレン（UHMWPE）モノマー市場の変数、動向、範囲

  • 市場イントロダクション / 系統展望
  • 市場規模と成長見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 医療グレード超高分子量ポリエチレン（UHMWPE）モノマー市場分析ツール
    • ポーターの分析
    • PESTEL分析

第4章 医療グレード超高分子量ポリエチレン（UHMWPE）モノマー市場：用途の推定・動向分析

  • セグメントダッシュボード
  • 医療グレード超高分子量ポリエチレン（UHMWPE）モノマー市場：用途変動分析、百万米ドル、数量：キロトン、2023年・2030年
  • 人工股関節全置換術
  • 膝関節置換術
  • 肩関節置換術
  • 足首置換術
  • 小さなジョイント

第5章 医療グレード超高分子量ポリエチレン（UHMWPE）モノマー市場：地域の推定・動向分析

  • 医療グレード超高分子量ポリエチレン（UHMWPE）モノマー市場シェア、地域別、2023年・2030年、百万米ドル、数量：キロトン
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • インドネシア
    • ベトナム
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 最近の動向と影響分析：主要市場参入企業別
  • 企業分類
  • 企業ヒートマップ分析
  • 企業プロファイル
    • Celanese Corporation
    • DSM Biomedical
    • Honeywell International Inc.
    • Mitsui Chemicals, Inc.
    • TEIJIN LIMITED
    • LyondellBasell Industries Holdings B.V.
    • Orthoplastics Ltd.
    • Tianyi Biomedical Technology Co., Ltd.
    • Quadrant Engineering Plastic Products（Mitsubishi Chemical Advanced Materials）
    • Asahi Kasei Corporation
目次
Product Code: GVR-1-68038-272-3

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Growth & Trends:

The global medical grade ultra high molecular weight polyethylene monomer market size is expected to reach USD 4.16 billion by 2030, registering a CAGR of 9.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. The effectiveness of the material in medical implants due to its superior properties such as high impact strength, low reactivity, and good flexibility is expected to drive the demand over the forecast period.

UHMWPE is a material having long chains which enable it to efficiently transfer load, thus making it suitable for implantation applications. The material is extremely pliable and has good impact strength. The material has less weight as compared to metals. All these properties have increased the demand for UHMWPE for medical applications in the recent past, and this trend is expected to continue over the forecast period.

Joint replacement surgeries use ultra high molecular weight polyethylene due to its effectiveness and versatility options. There has been a surge in demand for joint replacement surgeries across the globe. Rising geriatric population, changing lifestyle and lack of fitness are the contributing factors for this trend. This trend is expected to benefit the overall demand over next eight years.

Major industry participants are trying to develop innovative implantable products which have a longer life, are more comfortable, and give a strong mechanical performance. The market is characterized by few companies occupying a dominant revenue share. Companies are taking steps to increase the product portfolio and production capacity to meet the rising demand.

Medical Grade Ultra High Molecular Weight Polyethylene Monomer Market Report Highlights:

  • Knee replacements have accounted for the dominant share of 40.9% in 2023 owing to the increasing prevalence of osteoarthritis and other joint-related conditions.
  • Total hip replacement surgeries are expected to emerge at the fastest-growing CAGR during the forecast period owing to the escalating prevalence of osteoarthritis and rheumatoid arthritis.
  • The medical grade ultra high molecular weight polyethylene monomers market in Asia Pacific registered 40.5% as the dominant market share in 2023.
  • The North America medical grade ultra high molecular weight polyethylene monomers market secured 26.0% of the market share in 2023 owing to the region's growing investment in the healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million) (Volume in Kilotons)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Application Movement Analysis, USD Million, Volume in Kilotons, 2023 & 2030
  • 4.3. Total Hip Replacement
    • 4.3.1. Total Hip Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.4. Knee Replacement
    • 4.4.1. Knee Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.5. Shoulder Replacement
    • 4.5.1. Shoulder Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.6. Ankle Replacement
    • 4.6.1. Ankle Replacement Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 4.7. Small Joints
    • 4.7.1. Small Joints Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 5. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market: Regional Estimates & Trend Analysis

  • 5.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer tMarket Share, By Region, 2023 & 2030, USD Million, Volume in Kilotons
  • 5.2. North America
    • 5.2.1. North America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.2. U.S.
      • 5.2.2.1. U.S. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.3. Canada
      • 5.2.3.1. Canada Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.2.4. Mexico
      • 5.2.4.1. Mexico Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.3. Europe
    • 5.3.1. Europe Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.2. U.K.
      • 5.3.2.1. U.K. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.3. Germany
      • 5.3.3.1. Germany Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.4. France
      • 5.3.4.1. France Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.5. Italy
      • 5.3.5.1. Italy Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.6. Spain
      • 5.3.6.1. Spain Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.7. Russia
      • 5.3.7.1. Russia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.8. Demark
      • 5.3.8.1. Denmark Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.9. Sweden
      • 5.3.9.1. Sweden Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.3.10. Norway
      • 5.3.10.1. Norway Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.2. China
      • 5.4.2.1. China Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.3. Japan
      • 5.4.3.1. Japan Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.4. India
      • 5.4.4.1. India Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.5. Australia
      • 5.4.5.1. Australia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.6. South Korea
      • 5.4.6.1. South Korea Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.7. Indonesia
      • 5.4.7.1. Indonesia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.4.8. Vietnam
      • 5.4.8.1. Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.5. Latin America
    • 5.5.1. Latin America Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.5.2. Brazil
      • 5.5.2.1. Brazil Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.5.3. Argentina
      • 5.5.3.1. Argentina Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
  • 5.6. Middle East and Africa
    • 5.6.1. Middle East and Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. Saudi Arabia
      • 5.6.2.1. Saudi Arabia Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.3. South Africa
      • 5.6.3.1. South Africa Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.4. UAE
      • 5.6.4.1. UAE Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)
    • 5.6.5. Kuwait
      • 5.6.5.1. Kuwait Medical Grade Ultra High Molecular Weight Polyethylene (UHMWPE) Monomer Market Estimates and Forecasts, 2018 - 2030 (USD Million) (Volume in Kilotons)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis by Key Market Participants
  • 6.2. Company Categorization
  • 6.3. Company Heat Map Analysis
  • 6.4. Company Profiles
    • 6.4.1. Celanese Corporation
      • 6.4.1.1. Participant's Overview
      • 6.4.1.2. Financial Performance
      • 6.4.1.3. Product Benchmarking
      • 6.4.1.4. Recent Developments/ Strategic Initiatives
    • 6.4.2. DSM Biomedical
      • 6.4.2.1. Participant's Overview
      • 6.4.2.2. Financial Performance
      • 6.4.2.3. Product Benchmarking
      • 6.4.2.4. Recent Developments/ Strategic Initiatives
    • 6.4.3. Honeywell International Inc.
      • 6.4.3.1. Participant's Overview
      • 6.4.3.2. Financial Performance
      • 6.4.3.3. Product Benchmarking
      • 6.4.3.4. Recent Developments/ Strategic Initiatives
    • 6.4.4. Mitsui Chemicals, Inc.
      • 6.4.4.1. Participant's Overview
      • 6.4.4.2. Financial Performance
      • 6.4.4.3. Product Benchmarking
      • 6.4.4.4. Recent Developments/ Strategic Initiatives
    • 6.4.5. TEIJIN LIMITED
      • 6.4.5.1. Participant's Overview
      • 6.4.5.2. Financial Performance
      • 6.4.5.3. Product Benchmarking
      • 6.4.5.4. Recent Developments/ Strategic Initiatives
    • 6.4.6. LyondellBasell Industries Holdings B.V.
      • 6.4.6.1. Participant's Overview
      • 6.4.6.2. Financial Performance
      • 6.4.6.3. Product Benchmarking
      • 6.4.6.4. Recent Developments/ Strategic Initiatives
    • 6.4.7. Orthoplastics Ltd.
      • 6.4.7.1. Participant's Overview
      • 6.4.7.2. Financial Performance
      • 6.4.7.3. Product Benchmarking
      • 6.4.7.4. Recent Developments/ Strategic Initiatives
    • 6.4.8. Tianyi Biomedical Technology Co., Ltd.
      • 6.4.8.1. Participant's Overview
      • 6.4.8.2. Financial Performance
      • 6.4.8.3. Product Benchmarking
      • 6.4.8.4. Recent Developments/ Strategic Initiatives
    • 6.4.9. Quadrant Engineering Plastic Products (Mitsubishi Chemical Advanced Materials)
      • 6.4.9.1. Participant's Overview
      • 6.4.9.2. Financial Performance
      • 6.4.9.3. Product Benchmarking
      • 6.4.9.4. Recent Developments/ Strategic Initiatives
    • 6.4.10. Asahi Kasei Corporation
      • 6.4.10.1. Participant's Overview
      • 6.4.10.2. Financial Performance
      • 6.4.10.3. Product Benchmarking
      • 6.4.10.4. Recent Developments/ Strategic Initiatives